|
(P391) |
The role of Rac1 activator Tiam1 in cardiac hypertrophy and fibrosis |
| |
|
J. N. van Heuveln, E. Betz, M. Dewenter, J. Backs, T. Wieland, C. Vettel (Mannheim, Heidelberg) |
|
(P392) |
Cardiac specific overexpression of FYCO1 in vivo induces autophagy and blunts cardiac dysfunction due to pressure overload |
| |
|
M. Menke, I. Schmidt, F. Dierck, S. Hille, R. Lüllmann-Rauch, N. Frey, C. Kuhn (Kiel) |
|
(P393) |
The complex formation between TRPC3 and the immunophilin FKBP52 affects the hypertrophic response of cardiomyocytes |
| |
|
S. Bandleon, P. Strunz, A. Schaaf, A.-K. Lamprecht, J. Molkentin, K. Groschner, P. Eder-Negrin (Würzburg; Cincinnati, US; Graz, AT) |
|
(P394) |
The M-band protein Myomasp controls cardiomyocyte hypertrophy via negative regulation of calcineurin/NFAT signaling and is required to maintain M-Band integrity and contractile function in vivo |
| |
|
L. Köhler, P. Usinger, G. Freundt, N. Frey, M. Eden, DZHK (Kiel) |
|
(P395) |
Role of Carboxypeptidase member (CPXM)-2 on cardiac function in an experimental model of left ventricular hypertrophy induced by transverse aortic constriction |
| |
|
D. Lindner, P. M. Becher, M. Schwarzl, K. Grabowski, L. Herlan, S. Blankenberg, R. Kreutz, D. Westermann (Hamburg, Berlin) |